Raymond James Financial’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Raymond James Financial’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17M	Buy	1,105,575 +140,869	+15%	+$2.03M	﹤0.01%	1678
2026 Q1	$13.9M	Buy	964,706 +306,031	+46%	+$4.54M	﹤0.01%	1754
2025 Q4	$9.91M	Buy	658,675 +232,026	+54%	+$3.48M	﹤0.01%	1975
2025 Q3	$6.15M	Sell	426,649 -283,476	-40%	-$4.03M	﹤0.01%	2323
2025 Q2	$10.1M	Sell	710,125 -8,595	-1%	-$123K	﹤0.01%	1858
2025 Q1	$10.7M	Sell	718,720 -36,102	-5%	-$565K	﹤0.01%	1765
2024 Q4	$10.9M	Buy	+754,822	New	+$11.7M	﹤0.01%	1786

Other funds holding BMEZ

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return

Raymond James Financial's BMEZ Position: Q2 2026 in Review

Raymond James Financial increased its BlackRock Health Sciences Trust II (BMEZ) stake by 15% in Q2 2026, buying an estimated $2.03M and bringing the position to 1,105,575 shares worth $17M. The position accounts for ﹤0.01% of the portfolio, ranked #1678.

Raymond James Financial first reported a position in BMEZ in Q4 2024 and has held it in 7 quarters since. 88 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

Raymond James Financial held 1,105,575 shares of BlackRock Health Sciences Trust II worth $17M as of Q2 2026.
Raymond James Financial bought 140,869 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $2.03M.
BlackRock Health Sciences Trust II made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #1678 holding.
Raymond James Financial first reported a position in BlackRock Health Sciences Trust II in Q4 2024 and has held it in 7 quarters since.
88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.